Zobrazeno 1 - 10
of 2 254
pro vyhledávání: '"A. Ehmer"'
Autor:
Beaulieu, Daniel, Kornjaca, Milan, Krunic, Zoran, Stivaktakis, Michael, Ehmer, Thomas, Wang, Sheng-Tao, Pham, Anh
Machine learning has been increasingly utilized in the field of biomedical research to accelerate the drug discovery process. In recent years, the emergence of quantum computing has been followed by extensive exploration of quantum machine learning a
Externí odkaz:
http://arxiv.org/abs/2412.06758
Autor:
Strohm, Thomas, Wintersperger, Karen, Dommert, Florian, Basilewitsch, Daniel, Reuber, Georg, Hoursanov, Andrey, Ehmer, Thomas, Vodola, Davide, Luber, Sebastian
This is the second paper in a series of papers providing an overview of different quantum computing hardware platforms from an industrial end-user perspective. It follows our first paper on neutral-atom quantum computing. In the present paper, we pro
Externí odkaz:
http://arxiv.org/abs/2405.11450
Autor:
Stein, Jonas, Poppel, Michael, Adamczyk, Philip, Fabry, Ramona, Wu, Zixin, Kölle, Michael, Nüßlein, Jonas, Schuman, Daniëlle, Altmann, Philipp, Ehmer, Thomas, Narasimhan, Vijay, Linnhoff-Popien, Claudia
Publikováno v:
Proceedings of the 16th International Conference on Agents and Artificial Intelligence - Volume 3. ICAART 2024
Surrogate models are ubiquitously used in industry and academia to efficiently approximate given black box functions. As state-of-the-art methods from classical machine learning frequently struggle to solve this problem accurately for the often scarc
Externí odkaz:
http://arxiv.org/abs/2306.05042
Autor:
Wintersperger, Karen, Dommert, Florian, Ehmer, Thomas, Hoursanov, Andrey, Klepsch, Johannes, Mauerer, Wolfgang, Reuber, Georg, Strohm, Thomas, Yin, Ming, Luber, Sebastian
Publikováno v:
EPJ Quantum Technology 10, 32 (2023)
We present an industrial end-user perspective on the current state of quantum computing hardware for one specific technological approach, the neutral atom platform. Our aim is to assist developers in understanding the impact of the specific propertie
Externí odkaz:
http://arxiv.org/abs/2304.14360
Autor:
Riofrío, Carlos A., Mitevski, Oliver, Jones, Caitlin, Krellner, Florian, Vučković, Aleksandar, Doetsch, Joseph, Klepsch, Johannes, Ehmer, Thomas, Luckow, Andre
Publikováno v:
ACM Transactions on Quantum Computing, Volume 5, Issue 2 (2024)
Quantum generative modeling is a growing area of interest for industry-relevant applications. With the field still in its infancy, there are many competing techniques. This work is an attempt to systematically compare a broad range of these technique
Externí odkaz:
http://arxiv.org/abs/2301.09363
Autor:
Ahmed, Fasih Ali, Zia, Nukhba, Khan, Sameer Ahmad, Munir, Tahir, Mashreky, Saidur Rahman, Hashmi, Madiha, Al-Ibran, Ehmer, Rahman, AKM Fazlur, Khondoker, Sazzad, Asif, Fozia, Hyder, Adnan A., Latif, Asad
Publikováno v:
In Burns August 2024 50(6):1504-1512
Autor:
Theo Leitner, Cyrus Khandanpour, Knut Wendelin, Fuat Oduncu, Christoph Kimmich, Ralph Naumann, Miriam Kull, Hartmut Goldschmidt, Martin Ehmer, Claudia Kiewitz, Hans Salwender
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Therapy for relapsed and refractory multiple myeloma (RRMM) remains challenging. While monoclonal antibodies against CD38 combined with pomalidomide have demonstrated efficacy in clinical trials, real-world data remain sparse. We present real-world d
Externí odkaz:
https://doaj.org/article/73974d707b3149e7b998b3ae67a97e93
Autor:
Najib Ben Khaled, Marie Möller, Leonie S. Jochheim, Catherine Leyh, Ursula Ehmer, Katrin Böttcher, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Alexander Weich, Hans Benno Leicht, Valentina Zarka, Liangtao Ye, Julia Schneider, Ignazio Piseddu, Osman Öcal, Monika Rau, Friedrich Sinner, Marino Venerito, Simon Johannes Gairing, Friedrich Förster, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter
Publikováno v:
JHEP Reports, Vol 6, Iss 6, Pp 101065- (2024)
Background & Aims: Atezolizumab/bevacizumab (atezo/bev) and lenvatinib have demonstrated efficacy as first-line therapies for hepatocellular carcinoma (HCC). However, vascular endothelial growth factor (VEGF) inhibition with these therapies may be as
Externí odkaz:
https://doaj.org/article/8bfa5b4342fd47ce9b2a38f731714629
Autor:
Ben Khaled, Najib, Möller, Marie, Jochheim, Leonie S., Leyh, Catherine, Ehmer, Ursula, Böttcher, Katrin, Pinter, Matthias, Balcar, Lorenz, Scheiner, Bernhard, Weich, Alexander, Leicht, Hans Benno, Zarka, Valentina, Ye, Liangtao, Schneider, Julia, Piseddu, Ignazio, Öcal, Osman, Rau, Monika, Sinner, Friedrich, Venerito, Marino, Gairing, Simon Johannes, Förster, Friedrich, Mayerle, Julia, De Toni, Enrico N., Geier, Andreas, Reiter, Florian P.
Publikováno v:
In JHEP Reports June 2024 6(6)
Autor:
Bouleti, Claire, Servoz, Clement, Alos, Benjamin, Carsten, Ehmer, Jacquier, Alexis, Ternacle, Julien, Deux, Jean-François, Tea, Victoria, Mousseaux, Elie, Garcia, Rodrigue, Bonnet, Guillaume, Huttin, Olivier, Akodad, Mariama, Bejan-Angoulvant, Theodora, Lattuca, Benoit, Redheuil, Alban, Glatt, Nicolas, Angoulvant, Denis, Ou, Phalla
Publikováno v:
In Archives of Cardiovascular Diseases June-July 2024 117(6-7):433-440